Net profit of Amrutanjan Health Care rose 1.04% to Rs 19.45 crore in the quarter ended December 2025 as against Rs 19.25 crore during the previous quarter ended December 2024. Sales rose 14.90% to Rs 141.04 crore in the quarter ended December 2025 as against Rs 122.75 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales141.04122.75 15 OPM %17.8419.02 - PBDT29.2327.65 6 PBT27.6125.99 6 NP19.4519.25 1 Powered by Capital Market - Live News

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 03 February 2026, has recommended a Second Interim Dividend of Rs.1 per share (i.e.100%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 3 February 2026.Powered by Capital Market - Live News

Net profit of Amrutanjan Health Care rose 18.31% to Rs 13.96 crore in the quarter ended September 2025 as against Rs 11.80 crore during the previous quarter ended September 2024. Sales rose 7.08% to Rs 117.70 crore in the quarter ended September 2025 as against Rs 109.92 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales117.70109.92 7 OPM %14.0412.37 - PBDT20.7717.59 18 PBT19.2115.94 21 NP13.9611.80 18 Powered by Capital Market - Live News

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 10 November 2025, has recommended a First Interim Dividend of Rs.1 per share (i.e.100%), subject to the approval of the shareholders.Powered by Capital Market - Live News